Eledon Pharmaceuticals to present kidney transplant study data at congress

May 20, 2026 4:05 PM

Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) will present clinical data from its tegoprubart program for kidney transplant patients at the American ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found